Skip to main content

We are actively adding and checking records. If something is missing or looks wrong, please tell us, our team is working through reports. Report it

MedIndex
Beacon Pharmaceuticals PLC

Companies9/B/2,Toyenbee Circular Road Motijheel, Dhaka-1223

Beacon Pharmaceuticals PLC

0 brands · 332 generics

About Beacon Pharmaceuticals PLC

Beacon Pharmaceuticals PLC is a Bangladeshi pharmaceutical manufacturer established in 2006, with its corporate office at 9/B/2, Toyenbee Circular Road, Motijheel, Dhaka and its DGDA-registered address at Kathali, Bhaluka, Mymensingh. The company manufactures medicines across areas including oncology, cardiovascular care, gastrointestinal conditions and antibiotics, with a manufacturing plant in Bhaluka. 

What they manufacture

The company produces medicines in several therapeutic areas, including anti-cancer, cardiovascular, gastrointestinal, antibiotic, anticoagulant, antihistamine, analgesic and NSAID products. Its Bhaluka manufacturing plant covers about 30 acres and includes facilities for pharmaceutical preparations.

Beacon's manufacturing operations include oral and solid facilities, parenteral production, oncology facilities, and dedicated cephalosporin and penem facilities. Its cephalosporin facility is designed as a separate manufacturing area for beta-lactam antibiotics.

Registration and licensing

  • DGDA status: Functional
  • Licence category: Allopathic
  • DGDA registered address: Kathali, Bhaluka

An allopathic licence covers the manufacture of conventional modern medicines regulated under Bangladesh's drug-control framework. For this company, the Functional DGDA status indicates that the registered manufacturing licence is recorded as functional, while the listed validity date identifies the period covered by the licence record.

Manufacturing and quality standards

The company states that its Bhaluka manufacturing facility was designed with European pharmaceutical engineering expertise and to meet international manufacturing standards including WHO-cGMP, US FDA, UK MHRA and TGA Australia requirements. Its company materials also state that the dedicated cephalosporin facility has achieved EU GMP certification.

Beacon's recent manufacturing disclosures describe GMP-based production controls, laboratory practices and validation procedures, with sterile manufacturing operations aligned with European Union standards. 

Brands by Beacon Pharmaceuticals PLC

No brands are listed for this manufacturer yet.